Teva Pharmaceutical Industries
TEVA
#493
Rank
NZ$89.50 B
Marketcap
NZ$76.71
Share price
-0.92%
Change (1 day)
74.76%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2026 (TTM): NZ$0.77

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is NZ$0.82. In 2024 the company made an earnings per share (EPS) of NZ-$2.63 a decrease over its 2023 EPS that were of NZ-$0.85.

EPS history for Teva Pharmaceutical Industries from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.77
2024NZ-$2.63208.51%
2023NZ-$0.85-77.83%
2022NZ-$3.85-657.89%
2021NZ$0.69
2019NZ-$1.67-60.34%
2018NZ-$4.21-85.73%
2017NZ-$29.53-23328.57%
2016NZ$0.13-96.2%
2015NZ$3.34-48.6%
2014NZ$6.50138.67%
2013NZ$2.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.54 1,066.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29 57.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.60 340.12%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.80 120.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.93 1,482.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$5.23 539.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
NZ$0.66-19.54%๐Ÿ‡ฎ๐Ÿ‡ณ India